Company Search:
Advanced Search
Sponsored Links
Diasorin S.P.A. Company Snapshot
Diasorin S.P.A. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diasorin S.P.A. with three other pharmaceutical manufacturers in Europe: Sopharma AD of Bulgaria (2015 sales of 885.53 million Bulgarian Lev [US$497.21 million] of which 52% was Tablets), Synergy Health Plc of the United Kingdom (£408.82 million [US$502.86 million] of which 43% was Hospital Sterilisation Services), and Guerbet SA which is based in France (488.74 million Euro [US$536.48 million] of which 43% was X-rays).

Sales Analysis. During the year ended December of 2015, sales at Diasorin S.P.A. were 499.18 million Euro (US$547.95 million). This is an increase of 12.5% versus 2014, when the company's sales were 443.77 million Euro. This was the third consecutive year of growth at Diasorin S.P.A..
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Diasorin S.P.A.
  Stock Performance Chart for Diasorin S.P.A.
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 57.95
(Figures in Euro)
1 Week -0.4%   13 Weeks 1.8%  
4 Weeks 5.6%   52 Weeks 53.3%  
Diasorin S.P.A. Key Data:
  Ticker: DIA Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 499,181,000
(Year Ending Jan 2016).
Employees: 1,655
  Currency: Euro Market Cap: 3,172,664,391
  Fiscal Yr Ends: December Shares Outstanding: 54,748,307
  Share Type: Azioni Ordinaire Closely Held Shares: 31,943,658
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.